Noaiseh G, Sivils KL, Campbell K, Idokogi J, et al. Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjogren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial. Lancet 2025;406:2435-2448.
PMID: 41284548